Incidental findings from cancer next generation sequencing panels

Next-generation sequencing (NGS) technologies have facilitated multi-gene panel (MGP) testing to detect germline DNA variants in hereditary cancer patients. This sensitive technique can uncover unexpected, non-germline incidental findings indicative of mosaicism, clonal hematopoiesis (CH), or hemato...

Descripción completa

Detalles Bibliográficos
Autores principales: Maani, Nika, Panabaker, Karen, McCuaig, Jeanna M., Buckley, Kathleen, Semotiuk, Kara, Farncombe, Kirsten M., Ainsworth, Peter, Panchal, Seema, Sadikovic, Bekim, Armel, Susan Randall, Lin, Hanxin, Kim, Raymond H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289933/
https://www.ncbi.nlm.nih.gov/pubmed/34282142
http://dx.doi.org/10.1038/s41525-021-00224-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289933/
https://www.ncbi.nlm.nih.gov/pubmed/34282142
http://dx.doi.org/10.1038/s41525-021-00224-6

Ejemplares similares